share_log
Breakings ·  May 13 23:55
Novo Nordisk: MIM8 Frontier 2 clinical trials achieve a common primary endpoint.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment